What is Sanofi (SNY) Stock Return on Shareholders’ Capital?

Sanofi (NASDAQ: SNY) stock fell -2.95% on Friday to $38.76 against a previous-day closing price of $39.94. With 2.31 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.86 million shares. The 52-week range on SNY shows that it touched its highest point at $57.79 and its lowest point at $39.49 during that stretch. It currently has a 1-year price target of $60.17. With its current market cap of 97.98 billion, SNY has annualized dividend of $1.75 while the current yield stands at 4.51%. Beta for the stock currently stands at 0.52.

Top 5 Tech Stocks Every Investor Should Buy Right Now

While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.

Sign up here to get your free report now.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNY was down-trending over the past week, with a drop of -3.22%, but this was down by -5.37% over a month. Three-month performance dropped to -22.83% while six-month performance fell -24.64%. The stock lost -19.19% in the past year, while it has lost -22.22% so far this year. A look at the trailing 12-month EPS for SNY yields 2.64 with Next year EPS estimates of 4.41. For the next quarter, that number is 1.33. This implies an EPS growth rate of -49.30% for this year and 4.65% for next year. EPS is expected to grow by 12.30% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 7.80%.

Float and Shares Shorts:

At present, 2.50 billion SNY shares are outstanding with a float of 2.26 billion shares on hand for trading. On Jul 14, 2022, short shares totaled 2.31 million, which was 0.09% higher than short shares on Jun 14, 2022. In addition to Mr. Paul Hudson as the firm’s CEO & Director, Mr. Jean-Baptiste Chasseloup de Chatillon serves as its Exec. VP & CFO.


Institutional Ownership:

Through their ownership of 10.19% of SNY’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.69% of SNY, in contrast to 4.50% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in SNY with 3.04% of the stake, Dodge & Cox holds 76,997,282 shares worth 76,997,282. A second-largest stockholder of SNY, Fisher Asset Management LLC, holds 17,612,672 shares, controlling over 0.70% of the firm’s shares. T. Rowe Price Associates, Inc. is the third largest shareholder in SNY, holding 17,244,354 shares or 0.68% stake. With a 2.13% stake in SNY, the Dodge & Cox Stock Fund is the largest stakeholder. A total of 53,985,528 shares are owned by the mutual fund manager. The Dodge & Cox Balanced Fund, which owns about 0.22% of SNY stock, is the second-largest Mutual Fund holder. It holds 5,596,265 shares valued at 229.61 million. T Rowe Price Value Fund holds 0.20% of the stake in SNY, owning 5,122,796 shares worth 210.19 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SNY since 25 analysts follow the stock currently. There are 14 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 3 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SNY analysts setting a high price target of $66.30 and a low target of $42.55, the average target price over the next 12 months is $55.59. Based on these targets, SNY could surge 71.05% to reach the target high and rise by 9.78% to reach the target low. Reaching the average price target will result in a growth of 43.42% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. SNY will report FY 2022 earnings on 02/08/2023. Analysts have provided yearly estimates in a range of $4.16 being high and $3.95 being low. For SNY, this leads to a yearly average estimate of $4.05. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Sanofi surprised analysts by $0.04 when it reported $0.88 EPS against a consensus estimate of $0.84. The surprise factor in the prior quarter was $0.05. Based on analyst estimates, the high estimate for the next quarter is $1.38 and the low estimate is $1.21. The average estimate for the next quarter is thus $1.30.

Dividends & Yield:

In terms of dividends, SNY has a current ratio of $1.75, which is $1.75 over the trailing 12-months, while a dividend of $1.78 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and SNY currently yields $4.51. In the past year, SNY’s dividend yield has been $4.51, but when looking at the stock over the past five years, its yield has been $3.83. Accordingly, SNY has a current buyback yield of $0.32. This was $0.32 for the TTM, and it was $0.86 for the past five years.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]